Table 4. Seroprevalence of infections related to HIV in adults.
| Total N (%) | Women N (%) | Men N (%) | P-value | |
|---|---|---|---|---|
| HIV type | <0.001 | |||
| HIV 1 | 7954 (99.35) | 3454 (98.97) | 4500 (99.65) | |
| HIV 2 | 52 (0.65) | 36 (1.03) | 16 (0.35) | |
| Toxoplasma serology | 0.976 | |||
| Negative | 708 (85.3) | 297 (85.34) | 411 (85.27) | |
| Positive | 122 (14.7) | 51 (14.66) | 71 (14.73) | |
| VDRL test | 0.137 | |||
| Negative | 4551 (92.54) | 2005 (93.17) | 2546 (92.05) | |
| Positive | 367 (7.46) | 147 (6.83) | 220 (7.95) | |
| Hepatitis C serology | 0.645 | |||
| Negative | 765 (98.71) | 327 (98.49) | 438 (98.87) | |
| Positive | 10 (1.29) | 5 (1.51) | 5 (1.13) | |
| Hepatitis B surface Ag | <0.001 | |||
| Negative | 4592 (92.51) | 2055 (95.05) | 2537 (90.54) | |
| Positive | 372 (7.49) | 107 (4.95) | 265 (9.46) |
HBs Ag, Hepatitis B surface antigen; VDRL, Venereal Disease Research Laboratory.